Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Solifenacin Succinate MeSH Descriptor Data 2025


MeSH Heading
Solifenacin Succinate
Tree Number(s)
D03.605.687.900
D03.633.100.531.820.594
Unique ID
D000069464
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069464
Scope Note
A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.
Entry Term(s)
2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1- azabicyclo(2.2.2)oct-3-yl ester, (R-(R*,S*))-
Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate
Solifenacin
Vesicare
YM 905
YM905
Pharm Action
Muscarinic Antagonists
Urological Agents
Registry Numbers
KKA5DLD701
A8910SQJ1U
0
Related Numbers
242478-38-2
A8910SQJ1U
Public MeSH Note
2016; SOLIFENACIN SUCCINATE was indexed under QUINUCLIDINES and TETRAHYDROISOQUINOLINES 2003-2015; and under ISOQUINOLINES 2001-2003
History Note
2016 (2001)
Date Established
2016/01/01
Date of Entry
2015/07/09
Revision Date
2016/05/31
Solifenacin Succinate Preferred
Solifenacin Broader
YM905 Narrower
Vesicare Narrower
page delivered in 0.152s